[go: up one dir, main page]

DE69629805D1 - Biologische reagenzienkugel - Google Patents

Biologische reagenzienkugel

Info

Publication number
DE69629805D1
DE69629805D1 DE69629805T DE69629805T DE69629805D1 DE 69629805 D1 DE69629805 D1 DE 69629805D1 DE 69629805 T DE69629805 T DE 69629805T DE 69629805 T DE69629805 T DE 69629805T DE 69629805 D1 DE69629805 D1 DE 69629805D1
Authority
DE
Germany
Prior art keywords
biological reagent
reagent ball
ball
biological
reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69629805T
Other languages
English (en)
Other versions
DE69629805T2 (de
Inventor
B Treml
J Dall
A Draveling
F Jolly
P Ramanujam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Global Life Sciences Solutions USA LLC
Original Assignee
Pharmacia Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Biotech Inc filed Critical Pharmacia Biotech Inc
Application granted granted Critical
Publication of DE69629805D1 publication Critical patent/DE69629805D1/de
Publication of DE69629805T2 publication Critical patent/DE69629805T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/548—Carbohydrates, e.g. dextran
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/5432—Liposomes or microcapsules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/5436—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand physically entrapped within the solid phase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DE69629805T 1995-04-12 1996-04-05 Biologische reagenzienkugel Expired - Lifetime DE69629805T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/420,933 US5593824A (en) 1994-09-02 1995-04-12 Biological reagent spheres
US420933 1995-04-12
PCT/US1996/004701 WO1996032497A1 (en) 1995-04-12 1996-04-05 Biological reagent spheres

Publications (2)

Publication Number Publication Date
DE69629805D1 true DE69629805D1 (de) 2003-10-09
DE69629805T2 DE69629805T2 (de) 2004-07-15

Family

ID=23668455

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69629805T Expired - Lifetime DE69629805T2 (de) 1995-04-12 1996-04-05 Biologische reagenzienkugel

Country Status (7)

Country Link
US (2) US5593824A (de)
EP (1) EP0820521B1 (de)
JP (1) JP3006889B2 (de)
AU (1) AU697322B2 (de)
CA (1) CA2216780C (de)
DE (1) DE69629805T2 (de)
WO (1) WO1996032497A1 (de)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593824A (en) * 1994-09-02 1997-01-14 Pharmacia Biotech, Inc. Biological reagent spheres
US5824478A (en) * 1996-04-30 1998-10-20 Vysis, Inc. Diagnostic methods and probes
DE19622885A1 (de) * 1996-06-07 1997-12-11 Boehringer Mannheim Gmbh Reagenzzubereitung enthaltend magnetische Partikel in Form einer Tablette
US5968913A (en) * 1996-07-03 1999-10-19 Inspire Pharmaceuticals, Inc. Pharmaceutical compositions of uridine triphosphate
GB9705588D0 (en) * 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
AU736321B2 (en) * 1997-05-23 2001-07-26 Lynx Therapeutics, Inc. System and apparatus for sequential processing of analytes
CN1113690C (zh) * 1997-10-31 2003-07-09 范培昌 室温玻化机
US6306345B1 (en) * 1998-05-06 2001-10-23 Universal Preservation Technologies, Inc. Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures
US6692695B1 (en) 1999-05-06 2004-02-17 Quadrant Drug Delivery Limited Industrial scale barrier technology for preservation of sensitive biological materials
DE19922753A1 (de) * 1999-05-18 2000-11-23 Basf Ag Enzym-Instantformulierungen für die Tierernährung
US7030097B1 (en) * 1999-07-14 2006-04-18 Cornell Research Foundation, Inc. Controlled nucleic acid delivery systems
JP4536304B2 (ja) * 1999-07-14 2010-09-01 スペクトラル ダイアグノスティックス インコーポレイテッド 診断試験用球体の調製
US6207193B1 (en) 1999-12-27 2001-03-27 Stephen E. Feldman Transdermal drug delivery system
DE50012114D1 (de) 2000-09-05 2006-04-13 Zeltz Patrick Verfahren zur spezifischen Bestimmung von DNA-Sequenzen mittels paralleler Amplifikation
US6537666B1 (en) 2000-10-23 2003-03-25 Universal Preservation Technologies, Inc. Methods of forming a humidity barrier for the ambient temperature preservation of sensitive biologicals
ES2180416B1 (es) * 2001-03-12 2004-06-01 BIOTOOLS BIOTECHNOLOGICAL & MEDICAL LABORATORIES, S.A. Procedimiento para la preparacion de mezclas de reaccion estabilizadas, total o parcialmente desecadas, que comprenden, al menos, una enzima, mezclas de reaccion y kits que las contienen.
US20040101859A1 (en) * 2002-11-25 2004-05-27 Cepheid Compositions, methods and kits for polynucleotide amplification reactions and microfluidic devices
US20050069898A1 (en) * 2003-09-25 2005-03-31 Cepheid Lyophilized beads containing mannitol
US7846333B2 (en) * 2003-11-24 2010-12-07 Effendorf AG Porous media
US20060099567A1 (en) * 2004-04-08 2006-05-11 Biomatrica, Inc. Integration of sample storage and sample management for life science
US8900856B2 (en) 2004-04-08 2014-12-02 Biomatrica, Inc. Integration of sample storage and sample management for life science
US20060068399A1 (en) * 2004-09-24 2006-03-30 Cepheid Multiple bead reagent system for protein based assays with optimized matrices
US20060068398A1 (en) * 2004-09-24 2006-03-30 Cepheid Universal and target specific reagent beads for nucleic acid amplification
JP4699008B2 (ja) * 2004-11-02 2011-06-08 旭化成株式会社 酵素反応試薬
US8187557B2 (en) 2006-07-13 2012-05-29 Cepheid Reagent reservoir system for analytical instruments
JP5989957B2 (ja) * 2006-09-18 2016-09-07 ジーイー・ヘルスケア・バイオサイエンス・コーポレイション ガラス化生物試薬の調製
DE102006056790B3 (de) * 2006-12-01 2008-01-17 IfP Privates Institut für Produktqualität GmbH Laboreinmalartikel für Analyse und Diagnosik
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
US7738094B2 (en) 2007-01-26 2010-06-15 Becton, Dickinson And Company Method, system, and compositions for cell counting and analysis
GB0711683D0 (en) * 2007-06-16 2007-07-25 Enigma Diagnostics Ltd Compositions
US7816135B2 (en) 2007-07-05 2010-10-19 Becton, Dickinson And Company Method of analyzing lymphocytes
DE102008028908B3 (de) * 2008-06-18 2009-12-31 IfP Privates Institut für Produktqualität GmbH Nachweis eines Analyten in einem wässrigen Medium
CA2688174C (en) 2008-12-19 2018-08-07 F. Hoffmann-La Roche Ag Dry composition of reaction compounds with stabilized polymerase
IT1394539B1 (it) * 2009-05-19 2012-07-05 Sentinel Ch S P A Uso di uno stabilizzante delle polimerasi per la liofilizzazione e la preparazione di kit pronti per l'uso
AU2010258715B2 (en) 2009-06-12 2015-04-09 Perkinelmer Health Sciences, Inc. Rehydratable matrices for dry storage of TAQ polymerase in a microfluidic device
CN102803507B (zh) * 2009-06-12 2016-05-25 精密公司 用于微流体装置中在板反应剂的脱水储存的组合物及方法
AU2010350041B2 (en) * 2010-03-30 2014-06-26 C A Casyso Ag Composition for the determination of coagulation characteristics of a test liquid
CA2806670A1 (en) 2010-07-26 2012-02-09 Biomatrica, Inc. Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
EP2598661B1 (de) 2010-07-26 2017-09-27 Biomatrica, INC. Zusammensetzungen zur stabilisierung von dna, rna und proteinen in speichel- und anderen biologischen proben während des transports und der lagerung bei umgebungstemperaturen
EP2625285B1 (de) 2010-10-04 2020-04-29 Roche Diagniostics GmbH Verfahren für zelllyse und pcr im gleichen reaktionsgefäss
ES2533732T3 (es) 2010-10-04 2015-04-14 F. Hoffmann-La Roche Ag Método para lisis celular en un tampón de reacción de RT-PCR
TW201239086A (en) * 2011-03-23 2012-10-01 Genereach Biotechnology Corp Polymerase chain reaction solution
JP2013005796A (ja) * 2011-05-26 2013-01-10 Arkray Inc 乾燥試薬、乾燥試薬キット、試薬器、乾燥試薬の製造方法
US9528987B2 (en) 2011-06-23 2016-12-27 University Of Washington Reagent patterning in capillarity-based analyzers and associated systems and methods
EP4088736A1 (de) 2011-10-25 2022-11-16 Prothena Biosciences Limited Humanisierte anti-amyloid-antikörper-formulierungen und verfahren
US9480966B2 (en) 2012-04-30 2016-11-01 General Electric Company Substrates and methods for collection, stabilization and elution of biomolecules
US20140017318A1 (en) * 2012-07-10 2014-01-16 Kevin O'Connell Method to produce a medicinal product comprising a biologically active protein and the resulting product
US9314519B2 (en) 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
GB201219137D0 (en) * 2012-10-24 2012-12-05 Ge Healthcare Uk Ltd Direct nucleic acid amplification kit, reagent and method
US9618428B2 (en) 2012-11-30 2017-04-11 Ge Healthcare Uk Limited Biometric device and means for electronic storage and retrieval of biometric data
EP2934572A4 (de) 2012-12-20 2016-11-23 Biomatrica Inc Formulierungen und verfahren zur stabilisierung von pcr-reagenzien
US20150346097A1 (en) 2012-12-21 2015-12-03 Micronics, Inc. Portable fluorescence detection system and microassay cartridge
EP3549674B1 (de) 2012-12-21 2020-08-12 PerkinElmer Health Sciences, Inc. Filme mit geringere elastizität zur mikrofluidischen verwendung
EP2948249A1 (de) 2013-01-22 2015-12-02 University of Washington through its Center for Commercialization Sequenzielle freisetzung von flüssigkeitsmengen und zugehörige vorrichtungen, systeme und verfahren
US9393298B2 (en) 2013-03-15 2016-07-19 Intervet Inc. Liquid stable bovine virus vaccines
US9480739B2 (en) 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
WO2014182844A1 (en) 2013-05-07 2014-11-13 Micronics, Inc. Microfluidic devices and methods for performing serum separation and blood cross-matching
CN105189750B (zh) 2013-05-07 2020-07-28 珀金埃尔默健康科学有限公司 使用粘土矿物和碱性溶液制备含核酸样品的方法
CN105189784B (zh) 2013-05-07 2020-06-30 珀金埃尔默健康科学有限公司 用于制备和分析核酸的装置
AR097762A1 (es) 2013-09-27 2016-04-13 Intervet Int Bv Formulaciones secas de vacunas que son estables a temperatura ambiente
CN106232832B (zh) * 2013-12-06 2022-04-05 哈佛大学校长及研究员协会 基于纸的合成基因网络
US10202636B2 (en) 2013-12-24 2019-02-12 General Electric Company Electrospun fibers for protein stabilization and storage
AR099470A1 (es) 2014-02-17 2016-07-27 Intervet Int Bv Vacunas de virus de aves de corral líquidas
TWI670085B (zh) 2014-02-19 2019-09-01 荷蘭商英特威國際公司 液體穩定之豬病毒疫苗
EP3154338B1 (de) 2014-06-10 2020-01-29 Biomatrica, INC. Stabilisierung von thrombozyten bei umgebungstemperatur
FR3024780B1 (fr) * 2014-08-07 2018-11-30 Bertin Pharma Reactif pret a l'emploi
CN108473932B (zh) 2015-09-09 2022-07-15 集联健康有限公司 用于样品收集、稳定化和保存的系统、方法和装置
WO2017100212A1 (en) 2015-12-08 2017-06-15 Biomatrica, Inc. Reduction of erythrocyte sedimentation rate
US12195792B2 (en) 2016-02-05 2025-01-14 Gen-Probe Incorporated Dried amplification compositions
WO2018213811A1 (en) 2017-05-19 2018-11-22 Gen-Probe Incorporated Dried compositions containing flap endonuclease
WO2024240872A1 (en) 2023-05-23 2024-11-28 Biocartis Nv Cartridges comprising tablets

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3300474A (en) * 1964-02-12 1967-01-24 Pharmacia Ab Sucrose ether copolymerizates
DE1482489A1 (de) * 1965-01-13 1970-03-12 Boehringer Mannheim Gmbh Vollautomatisches Dragierverfahren
US3932943A (en) * 1970-08-14 1976-01-20 E. I. Du Pont De Nemours And Company Method of preparation of lyophilized biological products
US3721725A (en) * 1970-08-14 1973-03-20 Du Pont Process for preparing powder blends
DE2556561C2 (de) * 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von porösen Tabletten
JPH0126661B2 (de) * 1979-10-17 1989-05-24 Roquette Freres
US4372942A (en) * 1981-08-13 1983-02-08 Beecham Inc. Candy base and liquid center hard candy made therefrom
US4559298A (en) * 1982-11-23 1985-12-17 American National Red Cross Cryopreservation of biological materials in a non-frozen or vitreous state
JPS60129102A (ja) * 1983-12-15 1985-07-10 Fujirebio Inc 凍結乾燥物の製造方法
FI78117C (fi) * 1984-06-25 1989-06-12 Suomen Sokeri Oy Foerfarande foer framstaellning av ett stabilt glukosisomeraskoncentrat.
US4655047A (en) * 1985-03-25 1987-04-07 I.Q.F. Inc. Process for freezing or chilling
US4863856A (en) * 1985-04-04 1989-09-05 Verax Corporation Weighted collagen microsponge for immobilizing bioactive materials
ATE68524T1 (de) * 1985-07-09 1991-11-15 Quadrant Bioresources Ltd Beschuetzung von proteinen und aehnlichem.
EP0213653B1 (de) * 1985-08-19 1989-11-15 Akzo N.V. Gerät zur Durchführung einer immunochemischen Bestimmung
US4806343A (en) * 1986-03-13 1989-02-21 University Of Southwestern Louisiana Cryogenic protectant for proteins
US4897353A (en) * 1986-03-13 1990-01-30 University Of Southwestern Louisiana Cryogenic protection of phosphofructokinase using amino acids and zinc ions
US4820627A (en) * 1986-03-24 1989-04-11 Em Diagnostic Systems, Inc. Method of preparing particles suitable for tabletting into diagnostic reagents
US4762857A (en) * 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US5155024A (en) * 1986-07-10 1992-10-13 Eastman Kodak Company Binder composition and analytical element having stabilized peroxidase in layer containing the composition
US4712310A (en) * 1986-09-15 1987-12-15 E. I. Du Pont De Nemours And Company Co-spray technique
JP2562624B2 (ja) * 1986-11-07 1996-12-11 昭和電工株式会社 水溶性マイクロカプセルおよび液体洗剤組成物
US4753790A (en) * 1986-12-16 1988-06-28 Warner-Lambert Company Sorbitol coated comestible and method of preparation
US4848094A (en) * 1988-04-29 1989-07-18 Union Carbide Corporation Droplet freezing method and apparatus
GB8826429D0 (en) * 1988-11-11 1988-12-14 Univ Leeds Ind Service Ltd Enzyme stabilisation systems
GB8903593D0 (en) * 1989-02-16 1989-04-05 Pafra Ltd Storage of materials
US4997654A (en) * 1989-08-14 1991-03-05 Warner-Lambert Company Method for increasing salivation for xerostomia patients
US5200399A (en) * 1990-09-14 1993-04-06 Boyce Thompson Institute For Plant Research, Inc. Method of protecting biological materials from destructive reactions in the dry state
US5413732A (en) * 1991-08-19 1995-05-09 Abaxis, Inc. Reagent compositions for analytical testing
US5250429A (en) * 1991-09-20 1993-10-05 Pharmacia P-L Biochemicals Inc. Glassified restriction enzymes
US5288502A (en) * 1991-10-16 1994-02-22 The University Of Texas System Preparation and uses of multi-phase microspheres
US5593824A (en) * 1994-09-02 1997-01-14 Pharmacia Biotech, Inc. Biological reagent spheres

Also Published As

Publication number Publication date
DE69629805T2 (de) 2004-07-15
EP0820521B1 (de) 2003-09-03
JPH10511858A (ja) 1998-11-17
CA2216780A1 (en) 1996-10-17
EP0820521A1 (de) 1998-01-28
EP0820521A4 (de) 1999-11-03
US5763157A (en) 1998-06-09
WO1996032497A1 (en) 1996-10-17
US5593824A (en) 1997-01-14
CA2216780C (en) 2003-08-26
AU5386196A (en) 1996-10-30
JP3006889B2 (ja) 2000-02-07
AU697322B2 (en) 1998-10-01

Similar Documents

Publication Publication Date Title
DE69629805D1 (de) Biologische reagenzienkugel
DE69622395D1 (de) Biologische adsorptionsträger
DE69638156D1 (de) Probenkarte
DK1199569T3 (da) Pröveanalysesystem
BR9601190A (pt) Chumaço reagente
DE59609222D1 (de) Amperometrischer Biosensor
DE69617771D1 (de) Pyranose Oxidase enthaltender Biosensor
DE69803310D1 (de) Analytisches gerät mit kapillarreagenzträger
NO980220D0 (no) Reduksjon av biologisk forurensning
DE69600928D1 (de) Kapillar-mikroküvette
FI943667A0 (fi) Suljettu biologinen indikaattori
DE69840196D1 (de) Probenröhrchen
DE69617148D1 (de) Fühlerprobe
DE69800720D1 (de) Reagenz zur Färbung von Blutzellen
FI955611L (fi) Näytetunnistin
DE69608277D1 (de) Probenanalysegerät
DE19650512B4 (de) Federspitze
BR9702290A (pt) Ensaio de fator sanguíneo
FI944378A0 (fi) Biologisen informaation mittauslaite
FI941867A0 (fi) Reagenssiallas
DE69526203D1 (de) Biologische zielgerichtete mittel
DE69426354D1 (de) Reagenz zur bestimmung von glucose
DE69618904D1 (de) Probenanalyse
FI963862L (fi) Analyyttinen ilmaiseminen
SE9502764D0 (sv) Analytical assay

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: GE HEALTHCARE BIO-SCIENCES CORP. (N.D.GES.D.STAATE